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Chlamydia trachomatis genital infection continues to be an important public health
problem worldwide due to its increasing incidence. C. trachomatis infection can lead
to severe sequelae, such as pelvic inflammatory disease, obstructive infertility, and
preterm birth. Recently, it has been suggested that the cervico-vaginal microbiota
may be an important defense factor toward C. trachomatis infection as well as the
development of chronic sequelae. Therefore, the investigation of microbial profiles
associated to chlamydial infection is of the utmost importance. Here we present a pilot
study aiming to characterize, through the metagenomic analysis of sequenced 16s
rRNA gene amplicons, the cervical microbiota from reproductive age women positive
to C. trachomatis infection. The main finding of our study showed a marked increase
in bacterial diversity in asymptomatic C. trachomatis positive women as compared to
healthy controls in terms of Shannon’s diversity and Shannon’s evenness (P = 0.031 and
P = 0.026, respectively). More importantly, the cervical microbiota from C. trachomatis
positive women and from healthy controls significantly separated into two clusters in the
weighted UniFrac analysis (P = 0.0027), suggesting that differences between the two
groups depended entirely on the relative abundance of bacterial taxa rather than on the
types of bacterial taxa present. Furthermore, C. trachomatis positive women showed
an overall decrease in Lactobacillus spp. and an increase in anaerobes. These findings
are part of an ongoing larger epidemiological study that will evaluate the potential role of
distinct bacterial communities of the cervical microbiota in C. trachomatis infection.
Keywords: Chlamydia trachomatis, asymptomatic infection, cervical microbiota, next-generation sequencing,
bacterial diversity
INTRODUCTION
In recent years, a growing body of evidence highlighted that the cervico-vaginal microbiota plays
a key role in the outcomes of genital infections (Ma et al., 2012). In healthy reproductive women,
the cervico-vaginal microbiota is mostly populated by Lactobacillus spp., whose presence can be
considered as a hallmark of healthy conditions (Ma et al., 2012; van de Wijgert et al., 2014).
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Indeed, to date, it is widely accepted that cervico-vaginal
lactobacilli may have a significant impact on individual
susceptibility to genital infections (Brotman, 2011; Buve et al.,
2014). Specifically, lactobacilli are the main host defense factor
within the cervico-vaginal ecosystem, since they are able to
limit the growth of potential pathogens through different
mechanisms, including the competitive exclusion, competition
for nutrients, anti-microbial compound production, the immune
system activation as well as the maintenance of a low vaginal pH
(Mijac et al., 2006; Vielfort et al., 2008; O’Hanlon et al., 2013;
Doerflinger et al., 2014).
In addition to lactobacilli, other microorganisms populate
the cervico-vaginal microbiota, like, for example, Prevotella spp.,
Gardnerella vaginalis, and Atopobium vaginae. The replacement
of the Lactobacillus spp., with these microorganisms may result
in the switch from a healthy genital microbiota to a dysbiosis
defined as bacterial vaginosis (BV) (Srinivasan et al., 2012;
Dols et al., 2016). BV has been associated, in turn, with
an increased risk of acquiring sexually transmitted diseases,
including Chlamydia trachomatis (Hillier et al., 1992; Wiesenfeld
et al., 2003; Brotman et al., 2010; Petrova et al., 2015). C.
trachomatis is the leading cause of bacterial sexually transmitted
diseases and it is responsible for cervicitis, salpingitis, and
endometritis (World Health Organization, 2012). In particular,
it has been observed that women with BV may be at a higher risk
for C. trachomatis cervicitis, as suggested by a high Nugent score
(>7) in ∼85% of C. trachomatis infected women (Yoshimura
et al., 2009). More interesting, there is the evidence that C.
trachomatis genital infection increases the risk of acquiring and
transmitting human immunodeficiency virus (HIV) by three- to
four-fold (Galvin and Cohen, 2004; Buckner et al., 2016) as well
as of developing human papilloma virus (HPV) induced cervical
carcinoma (Jensen et al., 2014; Silva et al., 2014).
Nowadays, C. trachomatis infection continues to be an
important public health problem worldwide because of its
increasing incidence (World Health Organization, 2012). Indeed,
a 24% rise in the number of new cases has been observed since
2008 and this is likely due to a higher awareness of the impact
of C. trachomatis infection on female reproductive outcomes
(Newman et al., 2015). In fact, C. trachomatis genital infection
can lead to severe sequelae, such as pelvic inflammatory disease,
ectopic pregnancy, obstructive infertility as well as miscarriages
and preterm birth (Mylonas, 2012; Lanjouw et al., 2016), and the
risk of these long-term reproductive sequelae is likely increased
by the high rate (80%) of asymptomatic infections (Sessa et al.,
2015; Lanjouw et al., 2016).
Recently, several studies have demonstrated the protective
activity of vaginal Lactobacillus spp., as well as of other host
defense factors present in the healthy cervico-vaginal micro-
environment, toward C. trachomatis infection (Mastromarino
et al., 2014; Nardini et al., 2016; Sessa et al., 2017a,b). Specifically,
it has been showed that Lactobacillus crispatus and Lactobacillus
brevis are able to interfere with the early phases of C. trachomatis
infection as well as to inhibit its intracellular replication,
preventing the dissemination of the infection in the host
(Mastromarino et al., 2014; Sessa et al., 2017a). Therefore, the
complex interplay between the cervico-vaginal microbiota and
C. trachomatis seems to be critical for the onset of chlamydial
infection and the development of severe sequelae.
Given that alterations in microbial communities of the genital
tract may affect the susceptibility to C. trachomatis, investigating
the composition of cervical microbiota associated to chlamydial
infection is of the utmost importance. Therefore, here we present
a pilot study aiming to characterize, through the metagenomic
analysis of sequenced 16s rRNA gene amplicons, the cervical
microbiota from reproductive age women with asymptomatic C.
trachomatis infection.
MATERIALS AND METHODS
Study Design and Sample Collection
From May to September 2016, 45 consecutive women of Italian
origin, attending the Department of Gynaecology, Obstetrics and
Urology at “Sapienza” University of Rome for regular check-ups,
were enrolled in this study.
All women were not pregnant, of reproductive age, and
regularly menstruating. Women with recent or current antibiotic
and/or hormonal medications (oral or topic), as well as use of
probiotics and/or prebiotics, were excluded from the study.
All study participants gave their written informed consent
prior to sampling and provided a detailed personal, medical
and gynecological history. This study design and protocol
was approved by the Umberto I University Hospital ethical
committee (reference number 367/16) and was conducted
according to the principles expressed in the Declaration of
Helsinki.
From each woman, one endo-cervical swab (FLOQ swabs,
Copan) was collected for C. trachomatis testing as previously
described (Frieden et al., 2015), and for the metagenomic
analysis. All the women negative to C. trachomatis infection were
also screened for Neisseria gonorrhoeae, Trichomonas vaginalis,
Mycoplasma, Candida, HPV, and HSV-2 infections as previously
described (Frieden et al., 2015), in order to include exclusively
women with healthy genital conditions.
All study participants were also examined for BV and for the
presence of symptoms. BV was assessed using Amsel criteria and
confirmed using Gram stain criteria (Nugent score). Lastly, no
women had any specific genital symptoms related to chlamydial
infections.
All endo-cervical samples were placed in cryovials containing
1 mL of phosphate-buffered saline (PBS) and immediately stored
at−80◦C until further processing.
Next-Generation Sequencing
Cervical samples were shipped in dry ice to Microsynth
AG (Balgach, Switzerland) for DNA isolation, 16s rRNA
gene amplification, Illumina MiSeq sequencing and initial
bioinformatics analysis, consisting of raw data processing and
taxonomic classification.
DNA Isolation
Cervical samples were thawed and transferred into 2 mL
screwcap tubes (SarstedtInc, Germany) containing 10 µL of 4%
Tween 80 (Downey et al., 2012). Tubes were, then, vortexed for
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2 min on a TurboMix System (Scientific Industries, USA) and
350 µL of the sample were used for DNA isolation. Total DNA
was extracted using the QIAmp Investigator kit (QIAGEN, USA),
according to Manufacturer’s Instructions. DNA was quantified
by fluorescence spectroscopy (Quant-iTTM PicoGreen R© dsDNA
Assay Kit, Thermo Fisher, USA) and its integrity checked by
agarose gel electrophoresis.
16s rRNA Gene Amplification and Illumine
MiSeq Sequencing
Dual-indexed universal primers 341F (CCTACGGGNGGC
WGCAG) and 802R (GACTACHVGGGTATCTAATCC;
Illumina, USA) were utilized for the two-steps PCR amplification
of the V3–V4 hypervariable regions of the 16s rRNA gene
(16S/ITS Nextera two-step PCR kit, Illumina Inc., USA),
according to Manufacturer’s Instruction. Briefly, the first-step
PCR was carried on to amplify the V3–V4 region of the 16s
rRNA gene. The resulting PCR amplicons were then used for
the second-step PCR for further amplification and inclusion of
indexes (barcodes) as well as the Illumina sequencing adaptors.
Cycling conditions were initial denaturation at 95◦C for 3
min, followed by 20 cycles (for the first-step PCR) or 15 cycles
(for the second-step PCR) of denaturation at 98◦C for 20 s,
annealing at 56◦C for 30 s and elongation at 72◦C for 30 s, one
cycle of final elongation at 72◦C for 5 min and a final cooling
step to 10◦C. The resulting PCR products were quantified by
fluorescence spectroscopy (Quant-iT R©PicoGreen R© dsDNA
Assay Kit, Thermo Fisher, USA), pooled in equimolar amounts
and, then, purified with Agencourt AMpure-XP magnetic beads
(Beckman Coulter, USA). The final library containing all the
pooled samples was sequenced with version 2 of MiSeq Reagent
Kit, 2× 250 bp output, on a MiSeq desktop sequencer (Illumina,
USA). One negative control (350 µL of sterile PBS) was included
and subjected to the same procedures as the samples.
Sequencing Data Analysis
MiSeq paired-end reads were subjected to demultiplexing
and trimming of Illumina adaptor residuals using Illumina
recommended parameter settings (Illumina MiSeq Reporter
software, version 2.5.1.3). Sequences were aligned and joined
using Fast Length Adjustment of SHort reads (FLASH, version
1.2.11) (Magocˇ and Salzberg, 2011) and primers trimmed off the
aligned sequences using cutadapt (version 1.8.1) (Martin, 2011).
Chimeric sequences were identified and removed by UCHIME
(version 4.2) (Edgar et al., 2011) and only joined reads with an
average quality score of 25 or higher were used for downstream
analysis. Open reference operational taxonomic unit (OTU)
clustering and taxonomic assignment were performed in QIIME
(version 1.9.1) (Caporaso et al., 2010) using UCLUST against
the SILVA rRNA reference database (version 111) (Edgar, 2010;
Quast et al., 2013). An OTU was defined as a group of sequences
with a similarity of 97% or more. OTUs with only one sequence
(singletons) and those not found more than 10 times in any
sample were excluded from the downstream analysis to minimize
artifacts. OTUs that could not be identified to a species level using
the reference database, were searched using BLAST and assigned
to the deepest taxonomical level based on available published
data.
Taxa summaries were performed in QIIME and all samples
were normalized to the sample with the lowest read count
for alpha and beta diversity comparisons. Shannon’s diversity
index and Shannon’s evenness were used as metrics for alpha
rarefaction analysis, which was performed in QIIME. Jackknifed
principal coordinates analyses (PCoA) was used so to assure
that our rarefaction selection was not the cause of the observed
clustering patterns. PCoA analysis was based on unweighted and
weighted UniFrac distance matrixes and computed in QIIME
(Lozupone and Knight, 2005; Lozupone et al., 2007). For taxa
comparisons, relative abundances based on all obtained reads
were used.
Raw sequences were deposited into the NCBI’s Sequence
Read Archive (SRA) (https://trace.ncbi.nlm.nih.gov/Traces/sra/
sra.cgi?), accession number SRP098954.
Statistical Analysis
Non-parametric T-test based on Monte Carlo permutations was
used for alpha diversity comparisons, Kruskal–Wallis test for
taxa level comparisons, and Adonis for category comparisons of
distance matrixes, all calculated in QIIME. Benjamin–Hochberg
false discovery rate (FDR) correction was used to correct for
multiple hypothesis testing when necessary.
All remaining statistical calculations were performed in Excel
(Microsoft, USA) and R 3.1.2 (R development core team). Chi-
squared test was used for assessment of association of frequencies
among groups (Fisher’s exact test was used when any cell had
expected values <5). Mann–Whitney U-test for non-parametric
data was used for comparison of means. The single or multiple
inference significance level was set to 5%.
RESULTS
Study Subject Characteristics
Forty-five asymptomatic women of reproductive age were
enrolled in this study. Ten women were positive to C. trachomatis
(chlamydia group) and 35 were negative. Amongst the latter,
15 women were positive to other sexually transmitted infections
(STIs) and, hence, were excluded from further analysis, whereas
the remaining 20 were defined as healthy controls.
All 30 samples underwent 16s rRNA amplicon-based
microbiome analysis and 16 samples were excluded from
downstream analysis due to a number of reads <100.
Overall, the cervical microbiome analysis was performed on
14 cervical samples from 7 C. trachomatis positive women and
7 healthy controls. Population characteristics are summarized
in Table 1. No statistically significant differences were observed
between the two groups according to the risk factors commonly
associated with C. trachomatis infection.
Cervical Microbiota Composition
An average of 121,824 [median (IQR) 135,943 (77,506)] and
183,689 [median (IQR) 192,095 (17,689)] paired-end Illumina
reads were analyzed per sample in healthy controls and
chlamydia group, respectively. After the removal of singletons
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and rare OTUs, a total number of 22 OTUs from 16 genera
were identified [median (IQR) = 9 (5) and 15 (5.5) for
healthy controls and chlamydia groups, respectively]. The lowest
TABLE 1 | Characteristics of the study population.
Healthy controls
(n = 7)
C. trachomatis
positive
women (n = 7)
P-value*
Age (mean ± SD) 34.7 ± 6.8 26.9 ± 4.8 0.08
Smoking 28.6% (n = 2) 28.6% (n = 2) 1
First intercourse before age
16 years
14.3% (n = 1) 57.1% (n = 4) 0.26
New partner in the last 6
months
14.3% (n = 1) 71.4% (n = 5) 0.1
Multiple partners 28.6% (n = 2) 71.4% (n = 5) 0.29
Partner with past STI in the
last 6 months
0% 14.3% (n = 1) 1
Bacterial vaginosis (Nugent
score 7–10)
0% 42.9% (n = 3) 0.19
Past STI 0% 42.9% (n = 3) 0.19
Vaginal pH (mean ± SD) 4.78 ± 0.76 4.93 ± 0.95 0.8
SD, standard deviation; STI, sexually transmitted infection.
*P-values were calculated using the Chi-squared test (Fisher’s exact test when expected
values < 5) for the assessment of association of frequency among groups and the
Mann–Whiney U-test for comparison of means.
read count was 29,613 and, hence, OTUs were randomly sub-
sampled to 29,613 reads for further analysis to avoid sequencing
bias.
The cervical microbiome in healthy controls was dominated
by the phylum Firmicutes (median relative abundance 97.9%),
while bacteria from the phyla Actinobacteria, Fusobacteria,
Proteobacteria, and Tenericutes each accounted for <1% to
total bacteria. On genus level, Lactobacillus was the single
most abundant genus (median relative abundance 96.2%);
other genera (Gardnerella, Atopobium, Bifidobacterium, etc.)
were present, each contributing for <2% to total bacteria.
Specifically, L. crispatus or L. gasseri were the predominant
species in the majority of healthy women (86%), whereas in
the remaining women Lactobacillus iners was the predominant
species (Figures 1, 2).
Cervical samples from C. trachomatis positive women showed
a decrease in the phylum Firmicutes (median relative abundance
60.2% as compared to 97.9% in healthy controls) and an increase
in the phyla Actinobacteria (median relative abundance 16.1% as
compared to 0.09% in healthy controls).
Amongst the Firmicutes, Lactobacillus spp. was less abundant
in chlamydia groups than in healthy controls (median relative
abundance 60 and 98%, respectively). In particular, L. crispatus
or L. gasseri proportion was reduced in C. trachomatis positive
women as compared to healthy controls (overall median relative
abundance 89 and 32%, respectively; Figures 1, 2).
FIGURE 1 | Relative abundance of the observed species in cervical samples from C. trachomatis positive women and healthy controls. All values are mean ±
standard deviation. Kruskal–Wallis test with Benjamin–Hochberg false discovery rate (FDR) correction was used for taxa level comparisons between
chlamydia-positive women and healthy control.
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FIGURE 2 | Heatmap indicating the changes at the genus level of the cervical
microbial composition in C. trachomatis positive women and healthy controls.
The legend below the heatmap represents each participant. The relative
abundance of bacteria in each genus is indicated by a color gradient from
black (low abundance) to yellow (high abundance).
Actinobacteria were mostly represented by G. vaginalis
(median relative abundance 14.3% as compared to 0.07% in
healthy controls). Prevotella spp., belonging to the phylum
Bacteroidetes, was increased as well, with a median relative
abundance of 0.5 and 0.0001% in chlamydia group and healthy
controls, respectively.
Lastly, the proportion of strict and/or facultative anaerobes
was much higher in C. trachomatis positive women (median
relative abundance 39.8%) as compared to healthy controls
(median relative abundance 0.6%).
However, on phylum, class, order, family, genus, and OTU
levels, no statistically significant differences were observed
between chlamydia-positive patients and healthy controls.
Alpha and Beta Diversity Analyses
Alpha diversity analysis showed that C. trachomatis genital
infection was significantly associated to an increased diversity
of the cervical microbiota, as evidenced by Shannon’s diversity
index and Shannon’s evenness (Figures 3A,B, P = 0.031 and
P = 0.026, respectively).
In beta diversity analysis, cervical samples from healthy
controls showed a tendency toward a statistically significant
clustering, as compared to C. trachomatis positive women, in
weighted UniFrac analysis (P = 0.0027), suggesting shifts in
relative taxa abundance. In addition, the phylogenetic distances
between C. trachomatis positive samples were significantly
higher than the distances measured between healthy controls
(Figure 3C, P = 0.000004). On the contrary, no clustering
was observed when comparing unweighted UniFrac distance
matrixes (Figure 3D, P > 0.05).
DISCUSSION
This study investigates the cervical microbiota composition of
reproductive age women with asymptomatic C. trachomatis
genital infection. Via the metagenomic analysis of 16s rRNA
gene amplicons, we were able to determine the diversity and
richness of cervical microbiota from C. trachomatis positive
patients in comparison to women with a healthy cervical micro-
environment. A variety of statistical approaches was used to
provide a comprehensive evaluation of the cervical microbiota
in both groups.
Our main findings highlighted a notable difference of
the cervical microbiota of C. trachomatis positive women as
compared to healthy controls. In particular, we showed that the
cervical microbiota in asymptomatic C. trachomatis infection
had a higher microbial diversity than the cervical microbiota
in healthy controls, as evidenced by the marked increase in
Shannon’s diversity index as well as in Shannon’s evenness (P
= 0.031 and P = 0.026, respectively).
More importantly, we observed that the cervical microbiota
from C. trachomatis positive women and from healthy controls
significantly separated into two clusters in the weighted UniFrac
analysis (P = 0.0027). Weighted UniFrac is a beta diversity
measure that considers the phylogenetic distances as well as
differences in the relative abundance of taxa between two
microbial communities (Lozupone et al., 2007). On the contrary,
no clustering was observed between the two groups according
to the unweighted UniFrac analysis (P > 0.05), a qualitative
distance metric that only detects differences in the presence or
absence of lineages of bacteria (Lozupone and Knight, 2005).
These findings suggest that differences between C. trachomatis
positive women and healthy controls depended entirely on the
relative abundance of the phylogenetic lineages rather than the
types of lineages present. In fact, the taxa composition in both
groups was comparable, as evidenced by the presence of the same
genera (Lactobacillus, Prevotella, Gardnerella, etc.), whereas the
relative abundance of each taxa greatly differed between the two
groups.
As expected, we found that the cervical microbiota in
healthy controls was dominated mainly by Lactobacillus species;
specifically, L. crispatus and L. gasseriwere foundmore frequently
than L. iners.
Significant evidence suggest that the prevalence of specific
lactobacillus species is strongly correlated with genital health (Ma
et al., 2012; van de Wijgert et al., 2014; Petrova et al., 2015; Lewis
et al., 2017). In fact, L. crispatus, as well as L. gasseri, is known to
produce D-lactic acid, hydrogen peroxide (H2O2), bacteriocins
and other anti-microbial compounds that help protecting against
genital pathogens (Mitra et al., 2016).
L. iners as well is frequently found in healthy cervico-vaginal
microbiota, although its beneficial role is still debated. Indeed, L.
iners does not produce D-lactic acid as well as H2O2, and it has
been detected in cervico-vaginal dysbiosis, suggesting that it may
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FIGURE 3 | Alpha and beta diversity of the cervical microbiota from C. trachomatis positive women and healthy controls. Alpha rarefaction curves of Shannon’s
diversity index (A) and Shannon’s evenness (B). Samples were rarefied to the smallest observed number of reads (29,613). Principal coordinate analysis (PCoA) plots
of weighted (C) and unweighted (D) UniFrac distances. Each dot represents the cervical bacterial community composition of one chlamydia-positive woman or
healthy control. Groups were compared using Monte-Carlo permutations for alpha diversity and Adonis for beta diversity.
have a lower protective ability against pathogens as compared to
other lactobacillus species (Mitra et al., 2016; Petrova et al., 2017).
In our study, unlike the healthy controls, C. trachomatis
infection seemed to be accompanied by a decrease in the
abundance of lactobacilli, and an increase in facultative and/or
strict anaerobes, mostly G. vaginalis, A. vaginae, P. amnii, P.
timonensis, and Leptotrichia amnionii. A similar alteration in
cervico-vaginal microbiota related to C. trachomatis infection
was also found by Ma et al. (2013) and van der Veer et al. (2017).
The shift from a microbiota dominated by Lactobacillus
species to a microbiota characterized by the increased abundance
of anaerobes is a condition known as BV (Srinivasan et al.,
2012; Dols et al., 2016). Of note, in our study, 43% of C.
trachomatis positive women was affected by BV and 67% of
them had complex cervical microbial communities, characterized
by a greater species diversity and a very low abundance of
Lactobacillus species (<1%).
Concerning the structure of the microbial communities,
it emerged, from the weighted UniFrac analysis, a higher
inter-individual variability in C. trachomatis-positive women as
compared to healthy controls, suggesting that a unique cervical
microbial profile associated to C. trachomatis genital infection
could not be determined. In fact, different cervical microbial
profiles were observed; for example, in some cases, the cervical
microbiota was constituted exclusively by anaerobes like P.
amnii, P. timonensis, G. vaginalis, and L. amnionii, whereas, in
other cases, by L. gasseri, L. crispatus, or L. iners plus a mixture of
facultative and/or strict anaerobes.
L. iners was present in a higher number in C. trachomatis
positive women than in healthy controls and this finding is in
accordance with previous studies, showing that C. trachomatis
positive women were more likely to have a microbiota dominated
by L. iners (Ma et al., 2013; van der Veer et al., 2017). This may
be explained by the ability of L. iners to survive in a wide range of
pH and other metabolic stress-related conditions, adapting to an
altered cervico-vaginal environment (Petrova et al., 2017).
The main strength of our study is the inclusion, as control
group, exclusively of women with a healthy genital condition.
Women positive to other genital infections were excluded,
since pathogens, such as HPV, HIV, and N. gonorrhoeae, are
known to be associated to an altered cervico-vaginal microbiota
(Wiesenfeld et al., 2003; Petrova et al., 2013; Shannon et al., 2017).
In addition, we excluded women with recent or current use of
hormonal contraception and/or probiotic or prebiotic, all factors
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known to influence the cervico-vaginal microbial composition
over-time (Brotman et al., 2014; Recine et al., 2016).
The application of strict inclusion criteria allowed us to greatly
diminish the impact of the confounding bias associated to the
selection of the study population, leading, unfortunately, to a
small sample size. This is the main weakness of our study,
that prevented us to define a unique cervical microbial profile
associated to C. trachomatis infection. Notwithstanding, our data
may add up valuable information to the ongoing research on the
cervical microbiota associated to C. trachomatis genital infection,
since these are the first data on the diversity and composition of
the chlamydia-related endo-cervical microbiota.
In conclusion, our pilot study shows that C. trachomatis-
positive women have a heterogeneous cervical bacterial
community with increased species richness and diversity
dominated by facultative and/or strict anaerobes. A larger
epidemiological study investigating the richness and diversity
of the cervical microbial composition related to specific C.
trachomatis serotypes as well as chlamydial load is ongoing.
Our findings could have important clinical implications since
they may be considered as biomarker for disease progression
as well as for the restoring of a healthy cervical microbiota, so
to reduce the pathological outcomes of C. trachomatis infection
even if additional studies are needed.
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